Hematology/Oncology

Top Story

Most nonmelanoma skin cancers treated with other modalities found appropriate for Mohs surgery

August 3, 2015

Most nonmelanoma skin cancer cases treated with Mohs microscopic surgery during a 3-month period met appropriate use criteria, while other cases that met criteria for Mohs were treated by other modalities, according to recent study results.

A collaboration of dermatology organizations, including the American Academy of Dermatology, American Society for Dermatologic Surgery, American College of Mohs Surgery and American Society for Mohs Surgery, released the appropriate use criteria (AUC) for Mohs micrographic surgery (MMS) in September 2012.

In the Journals

Precancerous lesions increase risk for gastric cancer in low-risk population

August 3, 2015
A population-based cohort study in Sweden demonstrated patients with gastric precancerous lesions at all stages of progression based on Correa’s cascade increased…
In the Journals

Copy number alterations predict poor prognosis in adult ALL

August 3, 2015
Deletions of certain copy number alternations independently predicted poor prognosis for adolescent and adult patients with precursor B-cell acute lymphoblastic…
Caitlin C. Murphy, MPH, CPH In the Journals

Racial, insurance disparities influence chemotherapy receipt for colon cancer

August 3, 2015
Racial disparities in adjuvant chemotherapy receipt have recently reemerged among patients with stage III colon cancer, according to study results.The researchers…
Blog

BLOG: Patient financing also can be used as a marketing tool

August 3, 2015
I speak with health care practices on a regular basis. During these conversations, physicians usually ask a range of questions to help determine whether they should…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Multiple Myeloma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with multiple myeloma.
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
morganatic-roan